A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment.

Conclusion. We show that vigilance is required when interpreting galactomannan results in non-haematology patients to avoid potentially harmful overtreatment. PMID: 31746725 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31746725?dopt=Abstract

Source: Journal of Medical Microbiology - November 19, 2019 Category: Microbiology Authors: Martinelli AW, Patil P, Wong VK, Enoch DA, Sander CR Tags: J Med Microbiol Source Type: research